Patents by Inventor Daniel Michael Green

Daniel Michael Green has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Gonadotropin releasing hormone receptor antagonists
    Patent number: 7696210
    Abstract: Compounds of Formula I, useful as Gonadotropin Releasing Hormone (“GnRH”) (also known as Leutinizing Hormone Releasing Hormone) receptor antagonists, are disclosed.
    Type: Grant
    Filed: June 16, 2005
    Date of Patent: April 13, 2010
    Assignee: Wyeth
    Inventors: Lloyd Michael Garrick, Daniel Michael Green, Diane Barbara Hauze, Kenneth Lewis Kees, Joseph Theodore Lundquist, IV, Charles William Mann, John Francis Mehlmann, Jeffrey Claude Pelletier, John Francis Rogers, Jr., Jay Edward Wrobel
  • NAPHTHYLPYRIMIDINE, NAPHTHYLPYRAZINE AND NAPHTHYLPYRIDAZINE ANALOGS AND THEIR USE AS AGONISTS OF THE WNT-BETA-CATENIN CELLULAR MESSAGING SYSTEM
    Publication number: 20090054392
    Abstract: The present invention relates to naphthylpyrimidine analogs, methods of making naphthylpyrimidine analogs, compositions comprising a naphthylpyrimidine analog, and methods for treating canonical Wnt-?-catenin cellular messaging system-related disorders comprising administering to a subject in need thereof an effective amount of a naphthylpyrimidine, naphthylpyrazine and naphthylpyridazine analog.
    Type: Application
    Filed: August 19, 2008
    Publication date: February 26, 2009
    Applicant: Wyeth
    Inventors: Jeffrey Claude Pelletier, Luciana de Araujo Felix, Daniel Michael Green, Diane Barbara Hauze, Joseph Theodore Lundquist, IV, Charles William Mann, John Francis Mehlmann, John Francis Rogers, JR., Matthew Douglas Vera, Albert John Molinari
  • Novel Bicyclic and tricyclic pyrrolidine derivatives as GnRH antagonists
    Publication number: 20020065309
    Abstract: Bicyclic and tricyclic pyrrolidine derivatives are disclosed that are useful as antagonists of the GnRH receptor. Methods for using the novel compounds to treat GnRH-related disorders are also provided, as are pharmaceutical compositions and novel synthetic methods.
    Type: Application
    Filed: May 18, 2001
    Publication date: May 30, 2002
    Inventors: Ge Peng, Mark A. Gallop, Tania Chernov-Rogan, Stephen D. Yanofsky, Jeffrey Claude Pelletier, Daniel Michael Green